Article
Evaluating alloimmunization risk in patients with sickle cell disease and in prenatal care patients with RHCE variants.
Vox sanguinis - 1 May 2026
Leiva-Torres Gabriel André, Baillargeon Nadia, Constanzo-Yanez Jessica, Robitaille Nancy
Abstract excerpt
BACKGROUND AND OBJECTIVES: Clinically significant alloantibodies complicate transfusion and prenatal care, especially in individuals with genetic variants affecting high-frequency antigens. Many patients from African descent carry RHCE*ceVS alleles, which alter the expression of c (RH4), e (RH5) and hrB (RH31). However, the risk and clinical impact of alloimmunization remain uncertain. We evaluated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
